首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
UNITA' PIEGATRICE PER LA REALIZZAZIONE DI CONFEZIONI SIGILLATE CONTENENTI PRODOTTI ALIMENTARI VERSABILI
摘要
申请公布号
ITTO20070243(A1)
申请公布日期
2008.10.06
申请号
IT2007TO00243
申请日期
2007.04.05
申请人
TETRA LAVAL HOLDINGS & FINANCE SA
发明人
ANSALONI ROBERTO;SABBADINI DAVIDE
分类号
主分类号
代理机构
代理人
主权项
地址
您可能感兴趣的专利
ESPIGA PARA ENSAMBLAJE DE TABLEROS.
LAMPARA ESCAMOTEABLE PERFECCIONADA.
DISPOSITIVO DE SEÑALIZACION URBANA.
METHOD AND DEVICE FOR RELEASE OF GLASS PANEL FROM THE FRAME
METHOD FOR PRODUCTION OF A MEDICINAL PRODUCT METHOD FOR PRODUCTION OF A MEDICINAL PRODUCT
DNA COMPRISING PROMOTOR SEQUENCE (VARIANTS), AND TRANSGENIC PLANT TRANSFORMED WITH USE THEREOF
WATER-SOLUBLE PRODRUGS OF HINDERED ALCOHOLS OR PHENOLS, PHARMACEUTICAL COMPOSITION BASED THEREON, A METHOD FOR THE PREPARATION THEREOF, INTERMEDIARY COMPOUND (VARIANTS), AND A METHOD FOR THE PREPARATION THEREOF ( VARIANTS)
THERMOPLASTIC POLYVINYLCHLORIDE MOULDING COMPOSITION AND A METHOD FOR PREPARING THE SAME
HEPATITIS B VIRUS STRAIN, INDUCED BY VACCINE, NUCLEIC ACID ISOLATED MOLECULE CODING MUTANT MAIN SURFACE ANTIIGEN OF HEPATITIS B VIRUS, VECTOR AND VECTOR SYSTEM FOR THE PREPARATION OF POLYPEPTIDE, A METHOD FOR THE PREPARATION OF POLYPEPTIDE (VARIANTS), PURIFIED POLYPEPTIDE (VARIANTS), OLIGONUCLEOTIDE, A METHOD FOR THE PREPARATION OF ANTIBODIES (VARIANTS), ANTIBODY (VARIANTS), A METHOD FOR THE DETERMINATION OF CHEMICAL COMPOUND FOR TREATING THE INFECTION OF HEPATITIS B STRAIN INFECTION, A COMPOSITION, A METHOD FOR THE PREPARATION OF COMPOSITION, A METHOD OF ORGANISM LIQUIDS SCREENING FOR HEPATITIS B VIRUS, A METHOD OF ANTIBODY USE, VACCINE AGAINST HEPATITIS
Förfarande för att utföra positionsbestämning och elektronikanordning
8-substituerede 1,3,8-triazaspiro[4,5]decan-4-on-derivater
고압차단기의보조스위치구동장치
자동차의매연여과장치
헤드램프장착용실링콘넥터
METHOD FOR WRITING INFORMATION AND A DEVICE FOR THE REALIZATION OF THE METHOD
ANTIPARASITIC DERIVATIVES OF ARTEMISIN (ENDOPEROXIDES)
TREATMENT OF MUCUS HYPERSECRETION IN LUNGS BY ADMINISTRATION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGF-R) ANTAGONIST AND PHARMACEUTICAL FORMULATION
PHARMACEUTICAL COMPOSITION OF THIASOLIDINDION AND METFORMIN PROVIDING FOR PULSATING OR DELAYED RELEASE FOR ONE OF INGREDIENTS
METHOD OF AUTHENTICATION FOR AT LEAST ONE STATION AT DATA EXCHANGE
A POWDER WATER-SOLUBLE CELLULOSE DERIVATIVE AND A METHOD FOR THE PREPARATION THEREOF
